Mirati Therapeutics reported $-78985000 in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acceleron Pharma XLRN:US $ -69.47M 6.84M
Agios Pharmaceuticals AGIO:US $ -88.94M 0.07M
Alnylam Pharmaceuticals ALNY:US $ -169.89M 35.54M
Amgen AMGN:US $ 3228M 40M
Astellas Pharma 4503:JP Y 73000M 19058M
AstraZeneca AZN:LN 2784M 588M
Bayer BAYN:GR € 2089M 946M
Bluebird Bio BLUE:US $ -190.8M 44.05M
Bristol Myers Squibb BMY:US $ 5712M 33M
Eisai 4523:JP Y 15346M 49516M
Eli Lilly And LLY:US $ 2437.5M 639.8M
Exelixis EXEL:US $ 56.42M 70.25M
Gilead Sciences GILD:US $ 4370M 1605M
GlaxoSmithKline GSK:LN 3660M 1034M
Johnson & Johnson JNJ:US $ 8192M 2043M
Moderna Inc MRNA:US 3.63B 497M
Nektar Therapeutics NKTR:US $ -109.98M 3.32M
Novartis NOVN:VX SF 4837M 65M
Pfizer PFE:US $ 10235M 2245M
Puma Biotechnology PBYI:US $ -6.51M 7.18M
Sarepta Therapeutics SRPT:US $ -23.96M 135.16M
Seattle Genetics SGEN:US $ -281.36M 207.58M
Spectrum Pharmaceuticals SPPI:US $ -33.02M 10.98M
Takeda 4502:JP Y 238074M 153426M
Ultragenyx Pharmaceutical RARE:US $ -86.61M 6.96M
YTE INCY:US $ 262.16M 92.39M